共 127 条
[1]
Vogelmeier CF(2017)Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report: GOLD executive summary Eur Respir J 1 15076-212
[2]
Criner GJ(2015)Chronic obstructive pulmonary disease Nat Rev Dis Primers 18 198-136
[3]
Martinez FJ(2009)Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities Eur Respir Rev 1 129-38
[4]
Barnes PJ(2013)The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study Lancet Respir Med 54 24-172
[5]
Burney PG(2008)Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction Clin Chem 27 157-943
[6]
Silverman EK(2009)suPAR: the molecular crystal ball Dis Markers 3 932-125
[7]
Celli BR(2002)uPAR: a versatile signalling orchestrator Nat Rev Mol Cell Biol 6 119-31
[8]
Vestbo J(2011)Detection of suPAR in the saliva of healthy young adults: comparison with plasma levels Biomark Insights 10 2-365
[9]
Wedzicha JA(2012)suPAR as a prognostic biomarker in sepsis BMC Med 270 29-41
[10]
Wouters EF(2011)suPAR—a future risk marker in bacteremia J Intern Med 9 e98923-943